These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27672328)

  • 21. Proton therapy for small cell lung cancer.
    Verma V; Choi JI; Simone CB
    Transl Lung Cancer Res; 2018 Apr; 7(2):134-140. PubMed ID: 29876312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proton beam radiotherapy for patients with early-stage and advanced lung cancer: a narrative review with contemporary clinical recommendations.
    Chiang JS; Yu NY; Daniels TB; Liu W; Schild SE; Sio TT
    J Thorac Dis; 2021 Feb; 13(2):1270-1285. PubMed ID: 33717598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic review of the cost effectiveness of radiation therapy for prostate cancer from 2003 to 2013.
    Amin NP; Sher DJ; Konski AA
    Appl Health Econ Health Policy; 2014 Aug; 12(4):391-408. PubMed ID: 25022451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recommendations for the referral of patients for proton-beam therapy, an Alberta Health Services report: a model for Canada?
    Patel S; Kostaras X; Parliament M; Olivotto IA; Nordal R; Aronyk K; Hagen N
    Curr Oncol; 2014 Oct; 21(5):251-62. PubMed ID: 25302033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What Conditions Make Proton Beam Therapy Financially Viable in Western Canada?
    Smith WL; Smith CD; Patel S; Eisenstat DD; Quirk S; Mackenzie M; Olivotto IA
    Cureus; 2018 Nov; 10(11):e3644. PubMed ID: 30723643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The evolution of proton beam therapy: Current and future status.
    Tian X; Liu K; Hou Y; Cheng J; Zhang J
    Mol Clin Oncol; 2018 Jan; 8(1):15-21. PubMed ID: 29399346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dose distributions of proton beam therapy for hepatocellular carcinoma: a comparative study of treatment planning with 3D-conformal radiation therapy or intensity-modulated radiation therapy].
    Li JM; Yu JM; Liu SW; Chen Q; Mu XK; Jiang QA; Zhao MH; Zhang JG
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(45):3201-6. PubMed ID: 20193534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic review of methodology used in clinical studies evaluating the benefits of proton beam therapy.
    Ofuya M; McParland L; Murray L; Brown S; Sebag-Montefiore D; Hall E
    Clin Transl Radiat Oncol; 2019 Nov; 19():17-26. PubMed ID: 31372521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton beam therapy for hepatocellular carcinoma.
    Yeung RH; Chapman TR; Bowen SR; Apisarnthanarax S
    Expert Rev Anticancer Ther; 2017 Oct; 17(10):911-924. PubMed ID: 28825506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lifetime attributable risk of radiation-induced secondary cancer from proton beam therapy compared with that of intensity-modulated X-ray therapy in randomly sampled pediatric cancer patients.
    Tamura M; Sakurai H; Mizumoto M; Kamizawa S; Murayama S; Yamashita H; Takao S; Suzuki R; Shirato H; Ito YM
    J Radiat Res; 2017 May; 58(3):363-371. PubMed ID: 27789564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensity Modulated Proton Therapy with Advanced Planning Techniques in a Challenging Hepatocellular Carcinoma Patient.
    Apisarnthanarax S; Saini J; O'Ryan-Blair A; Castro J; Bowen SR
    Cureus; 2017 Sep; 9(9):e1674. PubMed ID: 29152431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
    Rwigema JM; Verma V; Lin L; Berman AT; Levin WP; Evans TL; Aggarwal C; Rengan R; Langer C; Cohen RB; Simone CB
    Cancer; 2017 Nov; 123(21):4244-4251. PubMed ID: 28678434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of proton therapy in treating base of skull chordoma.
    Austin AM; Douglass MJJ; Nguyen GT; Dalfsen R; Le H; Gorayski P; Tee H; Penniment M; Penfold SN
    Australas Phys Eng Sci Med; 2019 Dec; 42(4):1091-1098. PubMed ID: 31646441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant Proton Beam Therapy in the Management of Thymoma: A Dosimetric Comparison and Acute Toxicities.
    Parikh RR; Rhome R; Hug E; Tsai H; Cahlon O; Chon B; Goenka A
    Clin Lung Cancer; 2016 Sep; 17(5):362-366. PubMed ID: 27372386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A treatment planning comparison between proton beam therapy and intensity-modulated x-ray therapy for recurrent nasopharyngeal carcinoma.
    Liu SW; Li JM; Chang JY; Yu JM; Chen Q; Jiang QA; Mu XK; Zhao MH; Tian Y; Wei QL
    J Xray Sci Technol; 2010; 18(4):443-50. PubMed ID: 21045280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton therapy in the most common pediatric non-central nervous system malignancies: an overview of clinical and dosimetric outcomes.
    Sardaro A; Carbonara R; Petruzzelli MF; Turi B; Moschetta M; Scardapane A; Stabile Ianora AA
    Ital J Pediatr; 2019 Dec; 45(1):170. PubMed ID: 31881905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimal toxicity after proton beam therapy for prostate and pelvic nodal irradiation: results from the proton collaborative group REG001-09 trial.
    Chuong MD; Hartsell W; Larson G; Tsai H; Laramore GE; Rossi CJ; Wilkinson JB; Kaiser A; Vargas C
    Acta Oncol; 2018 Mar; 57(3):368-374. PubMed ID: 29034790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applying a variable relative biological effectiveness (RBE) might affect the analysis of clinical trials comparing photon and proton therapy for prostate cancer.
    Marteinsdottir M; Paganetti H
    Phys Med Biol; 2019 Jun; 64(11):115027. PubMed ID: 31082810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton beam therapy in paediatric cancer: Anticipating the opening of the Australian Bragg Centre for Proton Therapy and Research.
    Khong J; Tee H; Gorayski P; Le H; Penniment M; Jessop S; Hansford J; Penfold M; Green J; Skelton K; Saran F
    J Med Imaging Radiat Oncol; 2023 Dec; ():. PubMed ID: 38146017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and current status of proton therapy for lung cancer in Korea.
    Yoon M
    Thorac Cancer; 2012 Feb; 3(1):1-7. PubMed ID: 28920263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.